Annual report pursuant to Section 13 and 15(d)

INVESTMENTS - Narrative (Details)

v3.23.1
INVESTMENTS - Narrative (Details)
€ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
Dec. 21, 2018
EUR (€)
Apr. 30, 2022
USD ($)
shares
Apr. 30, 2022
EUR (€)
shares
Dec. 31, 2020
USD ($)
Jan. 31, 2019
EUR (€)
Sep. 30, 2020
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
€ / shares
Dec. 01, 2020
Nov. 30, 2020
Sep. 30, 2020
EUR (€)
Sep. 30, 2019
USD ($)
shares
Sep. 30, 2019
EUR (€)
shares
Dec. 31, 2018
USD ($)
Dec. 31, 2018
EUR (€)
Dec. 21, 2018
USD ($)
tranche
shares
Dec. 21, 2018
EUR (€)
tranche
€ / shares
shares
Summary of Investment Holdings [Line Items]                                    
Investment | $             $ 5,679 $ 1,458                    
Goodwill | $       $ 18,508     0 0                    
Gain (loss) on investments | $             (6,851) 0                    
Proceeds from partial sale of equity method investment | $             2,498 0                    
Loss on equity method investment, net | $             64 95                    
Seed Financing Round | Cansativa                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued (in shares) | shares                                 3,096 3,096
Investments, fully diluted pre-money valuation                                   € 8,500,000
Preferred Shares | Cansativa                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued, price per share (euro per share) | € / shares                 € 543.31                  
Preferred Shares | Seed Financing Round | Cansativa                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued, price per share (euro per share) | € / shares                                   € 322.97
Cansativa                                    
Summary of Investment Holdings [Line Items]                                    
Percentage of interest held   7.60%                                
Gain (loss) on investments | $       $ 211     6,851                      
Sale of stock, number of shares issued/sold in transaction (in shares) | shares   1,586 1,586                              
Proceeds from partial sale of equity method investment     € 2,300,000                              
Gain (loss) on sale of equity method investments | $   $ 1,983                                
Additional gain (loss) on equity method investments | $   $ 4,868                                
Loss on equity method investment, net | $             $ 64 $ 95                    
Cansativa | Cansativa, Employee Stock Ownership Plan (ESOP)                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued (in shares) | shares   992                                
Cansativa | Tranche One                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                                   € 1,000,000
Cansativa | Seed Financing Round                                    
Summary of Investment Holdings [Line Items]                                    
Investments, net                                   € 7,000
Number of investment tranches | tranche                                 3 3
Percentage of interest held                                 10.53% 10.53%
Payments to acquire investments € 3,100       € 996,820                          
Share price (euro per share) | € / shares                                   € 1.00
Investment                             $ 1,075 € 999,920    
Investments, initial amount                               3,100    
Investments, capital reverse payment                               € 996,820    
Investments, additional                         $ 722 € 650,000        
Investments, additional, shares (in shares) | shares                         2,138 2,138        
Investments, consideration transferred, net assets                         16.60% 16.60%        
Net assets                           € 1,233,000        
Goodwill                           € 1,122,000        
Cansativa | Seed Financing Round | Cansativa, Employee Stock Ownership Plan (ESOP)                                    
Summary of Investment Holdings [Line Items]                                    
Percentage of interest held                   15.80% 16.59%              
Cansativa | Seed Financing Round | Tranche One                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                                 $ 1,075 € 999,920
Cansativa | Seed Financing Round | Tranche Two                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                       € 0           3,000,000
Gain (loss) on investments | $           $ (370)                        
Cansativa | Seed Financing Round | Tranche Three                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                                   € 3,000,000
Cansativa | Common Shares                                    
Summary of Investment Holdings [Line Items]                                    
Number of shares registered and fully paid-in capital (in shares) | shares                                 26,318 26,318
Cansativa | Preferred Shares | Series B Preferred Stock                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued (in shares) | shares   10,184                                
Cansativa | Preferred Shares | Seed Financing Round                                    
Summary of Investment Holdings [Line Items]                                    
Percentage of interest held       14.22%           15.80%